Three of Cork’s highest-achieving female STEM students were today recognised by Stryker, a global leader in medical technologies, at the WISE UP Technological Awards to celebrate outstanding academic ...

Let’s dig into the relative performance of Neogen (NASDAQ:NEOG) and its peers as we unravel the now-completed Q3 medical ...

Despite operational strength, SYK trades at a significant valuation premium to sector peers, with a PEG ratio above 2 and ...

Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. Learn more about SYK stock here.

Stryker completed two strategic acquisitions: Guard Medical’s NPseal products and advanced medical balloons. These acquisitions are set to enhance their orthopedic instrument offerings and Sage ...

Stryker (SYK) reported current net profit margins of 12.1%, a step down from last year’s 16.3%, with the latest results ...

The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Medical technology company Stryker (NYSE:SYK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP profit of $3.19 per share was 1.9% ...

Stryker is flat since the beginning of the year, and at $357.78 per share, it is trading 11.3% below its 52-week high of $403 ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...

Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

The medical device maker posted revenue of $6.06 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $6.04 billion. Stryker expects full-year earnings in ...